NCT02112422View on ClinicalTrials.gov

The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Pregnancy
Interventions
DRUG

Control

The control group will receive 0.15 mg/kg of intravenous dexamethasone (maximum dose 20mg) in 100ml normal saline immediately prior to skin incision.

DRUG

Intervention

Patients in the intervention group will receive 0.15 mg/kg of intravenous dexamethasone (maximum dose 20mg) in 100ml normal saline 45-60 minutes prior to the OR.

Trial Locations (2)

R3A1R9

Health Sciences Center, Winnipeg

R3Y-0A9

Winnipeg Health Sciences Center, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT02112422 - The Role of Timing of Dexamethasone Administration on Pain Scores and Quality of Recovery in Cesarean Section. | Biotech Hunter | Biotech Hunter